1. Home
  2. RYZ vs SGP Comparison

RYZ vs SGP Comparison

Compare RYZ & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation Common Stock

RYZ

Ryerson Holding Corporation Common Stock

N/A

Current Price

$20.74

Market Cap

1.0B

Sector

Industrials

ML Signal

N/A

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$25.82

Market Cap

932.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RYZ
SGP
Founded
1842
2019
Country
United States
United States
Employees
4300
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
932.9M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
RYZ
SGP
Price
$20.74
$25.82
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.00
AVG Volume (30 Days)
459.6K
93.8K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
3.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.61
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.34
$24.71
52 Week High
$27.72
$30.56

Technical Indicators

Market Signals
Indicator
RYZ
SGP
Relative Strength Index (RSI) 13.90 48.38
Support Level N/A $25.66
Resistance Level N/A $29.83
Average True Range (ATR) 0.97 1.63
MACD -0.36 -0.13
Stochastic Oscillator 17.35 27.89

Price Performance

Historical Comparison
RYZ
SGP

About RYZ Ryerson Holding Corporation Common Stock

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company has one operating and reportable segment, metals service centers. It derives substantially all of its sales from the processing and distribution of met. Geographically, the majority revenue is generated from the United States.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: